Ipca Laboratories has reported results for first quarter ended June 30, 2014.
The company has posted over two fold jump in its net profit to Rs 145.49 crore as compared to Rs 71.70 crore for the quarter ended June 30, 2013. Its total income from operations has increased by 16.32% to Rs 942.25 crore for the quarter under review from Rs 810.01 crore for the corresponding quarter of the previous year.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
